These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 16213330

  • 21. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S, Lee SG, Joh JW, Suh KS, Kim DG.
    Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
    [Abstract] [Full Text] [Related]

  • 22. Expanded criteria for hepatocellular carcinoma and liver transplantation.
    Moray G, Karakayali F, Yilmaz U, Ozcay F, Bilezikci B, Haberal M.
    Transplant Proc; 2007 May; 39(4):1171-4. PubMed ID: 17524923
    [Abstract] [Full Text] [Related]

  • 23. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I, Sotiropoulos GC, Lang H, Nadalin S, Beckebaum S, Sgourakis G, Saner FH, Radtke A, Papanikolaou V, Baba HA, Paul A, Broelsch CE, Malagó M.
    Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
    [Abstract] [Full Text] [Related]

  • 24. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
    Shimada M, Yonemura Y, Ijichi H, Harada N, Shiotani S, Ninomiya M, Terashi T, Yoshizumi T, Soejima Y, Maehara Y.
    Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
    [Abstract] [Full Text] [Related]

  • 25. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 26. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
    Jonas S, Mittler J, Pascher A, Schumacher G, Theruvath T, Benckert C, Rudolph B, Neuhaus P.
    Liver Transpl; 2007 Jun; 13(6):896-903. PubMed ID: 17538994
    [Abstract] [Full Text] [Related]

  • 27. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?
    Lee KW, Park JW, Joh JW, Kim SJ, Choi SH, Heo JS, Lee HH, Lee DS, Park JH, Yoo BC, Paik SW, Koh KC, Lee JH, Choi MS, Lee SK.
    Transplant Proc; 2004 Oct; 36(8):2289-90. PubMed ID: 15561222
    [Abstract] [Full Text] [Related]

  • 28. Orthotopic liver transplantation for hepatocellular carcinoma: one center's experience in the Northeast of Brazil.
    Coelho GR, Vasconcelos KF, Vasconcelos JB, Barros MA, Costa PE, Borges GC, Júnior JT, Brasil IR, Filho DH, Viana CF, Rocha TD, Mesquita DF, Garcia JH.
    Transplant Proc; 2009 Jun; 41(5):1740-2. PubMed ID: 19545719
    [Abstract] [Full Text] [Related]

  • 29. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK.
    Dig Dis; 2007 Jun; 25(4):313-9. PubMed ID: 17960066
    [Abstract] [Full Text] [Related]

  • 30. Hepatocellular carcinoma in unrelated viral cirrhosis: long-term results after liver transplantation.
    Lauterio A, Di Sandro S, Slim A, Giacomoni A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L.
    Transplant Proc; 2010 May; 42(4):1212-5. PubMed ID: 20534264
    [Abstract] [Full Text] [Related]

  • 31. Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China.
    Xiao L, Fu ZR, Ding GS, Fu H, Ni ZJ, Wang ZX, Shi XM, Guo WY.
    Transplant Proc; 2009 Jun; 41(5):1717-21. PubMed ID: 19545714
    [Abstract] [Full Text] [Related]

  • 32. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
    Rayya F, Harms J, Bartels M, Uhlmann D, Hauss J, Fangmann J.
    Transplant Proc; 2008 May; 40(4):933-5. PubMed ID: 18555082
    [Abstract] [Full Text] [Related]

  • 33. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.